Basic Information
| LncRNA/CircRNA Name | HRCEG |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qRT-PCR, RNAi, Western blot |
| Sample | cell line MKN28 and BGC823,gastric cancer samples |
| Expression Pattern | down-regulated |
| Function Description | HRCEG significantly under-expressed in gastric cancer.HRCEG might inhibit gastric cancer progress by regulating cell proliferation and apoptosis.HRCEG suppresses EMT process in gastric cancer cells.HDAC1 suppressed HRCEG transcription in gastric cancer cells. |
| Pubmed ID | 31964588 |
| Year | 2020 |
| Title | LncRNA HRCEG, Regulated by HDAC1, Inhibits Cells Proliferation and Epithelial-Mesenchymal-Transition in Gastric Cancer |
External Links
| Links for HRCEG | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |